Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Aventis presents new NHE-3 inhibitors

April 30, 2001

Zeffix may represent a major advance for children with chronic HBV, according to EASL presentation

April 26, 2001

Potential of LTbetaR-Ig for colitis Rx discussed at Tokyo meeting

April 26, 2001

Prodrug of beta-L-dC with improved oral bioavailability and systemic delivery

April 25, 2001

PowderJect's hepatitis B DNA vaccine elicits high immunogenicity in nonresponders

April 25, 2001

Chinese herbal preparation tested in patients with chronic HCV

April 24, 2001

72-week results from phase II study of Ceplene in hepatitis C patients

April 24, 2001

Gastric prokinetic agents with a quinazoline structure in development at Kyowa Hakko

April 23, 2001

L-dT safe and effective in patients with chronic HBV infection according to preliminary data

April 23, 2001

Use of cariporide in liver fibrosis discussed at EASL meeting

April 23, 2001

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...